Disgraced investor Neil Woodford plans to start a new biotech investment firm as he seeks to capitalise on a booming UK life sciences industry and rebuild his reputation following the collapse of his previous fund.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,